HPTN
May 17, 2021 | Stories from the Field
Growing up in Cameroon, Rita Sondengam was no stranger to the faces that hide behind the numbers of some of the world’s most pressing public health emergencies like HIV/AIDS, malaria, dysentery, and TB. But for her, these weren’t just statistics, faceless numbers in a...
Feb 17, 2021 | News
Sponsored by the National Institutes of Health (NIH), the HIV Prevention Trials Network (HPTN) and the HIV Vaccine Trials Network (HVTN) jointly conducted the Antibody Mediated Prevention (AMP) study which tested a new innovation for HIV prevention. Traditionally,...
Dec 10, 2020 | News
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was noted in a Dec 7 article in POZ magazine which discussed how the national system of HIV clinical trials has been reorganized and refined. Specifically, the new structure divides trials into four distinct...
Dec 3, 2020 | News
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was featured in a Nov 30 article by Global News Wire which announced that ICAP has been awarded a seven-year grant from the U.S. National Institutes of Health as part of the next funding cycle (2020-2027) for the...
Jul 7, 2020 | News
Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected once every eight weeks was superior to daily oral...
